gC1q receptor ligation selectively down-regulates human IL-12 production through activation of the phosphoinositide 3-kinase pathway

Journal of Immunology

Volumn 175, Issue 7, 2005, Pages 4706-4714

  Waggoner, Stephen N ^a,b   Cruise, Michael W ^a,b   Kassel, Rachel ^a,b   Hahn, Young S ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1Q RECEPTOR; COMPLEMENT RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RECOMBINANT GAMMA INTERFERON; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; CROSS LINKING; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; VIRUS INFECTION; WESTERN BLOTTING;

EID: 25444465640     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.7.4706     Document Type: Article

References (53)

1. Gasque, P. 2004. Complement: a unique innate immune sensor for danger signals. Mol. Immunol. 41: 1089-1098.
2. Carroll, M. C. 2004. The complement system in regulation of adaptive immunity. Nat. Immunol. 5: 981-986.
3. Blue, C. E., O. B. Spiller, and D. J. Blackboum. 2004. The relevance of complement to virus biology. Virology 319; 176-184.
4. McGreal, E., and P. Gasque. 2002. Structure-function studies of the receptors for complement CIq. Biochem. Soc. Trans. 30: 1010-1014.
5. Arlaud, G. J., C. Gaboriaud, N. M. Thielens, and V. Rossi. 2002. Structural biology of C1. Biochem. Soc. Trans. 30: 1001-1006.
6. Ghebrehiwet, B., and E. I. Peerschke. 2004. cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection. Mol. Immunol. 41: 173-183.
7. Hannema, A. J., J. C. Kluin-Nelemans, C. E. Hack, A. J. Eerenberg-Belmer, C. Mallee, and H. P. van Helden. 1984. SLE like syndrome and functional deficiency of CIq in members of a large family. Clin. Exp. Immunol. 55: 106-114.
8. Kirschfink, M., F. Petty, K. Khirwadkar, R. Wigand, J. P. Kaltwasser, and M. Loos. 1993. Complete functional C1q deficiency associated with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 94: 267-272.
9. Botto, M., C. Dell'Agnola, A. E. Bygrave, E. M. Thompson, H. T. Cook, F. Petty, M. Loos, P. P. Pandolfi, and M. J. Walport. 1998. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19: 56-59.
10. Chen, A., S. Gaddipati, Y. Hong, D. J. Volkman, E. I. Peerschke, and B. Ghebrehiwet. 1994. Human T cells express specific binding sites for C1q: role in T cell activation and proliferation. J. Immunol. 153: 1430-1440.
11. Yamada, M., K. Oritani, T. Kaisho, J. Ishikawa, H. Yoshida, I. Takahashi, S. Kawamoto, N. Ishida, H. Ujiie, H. Masaie, et al. 2004. Complement C1q regulates LPS-induced cytokine production in bone marrow-derived dendritic cells. Eur. J. Immunol. 34: 221-230.
12. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3: 133-146.
13. Kang, B. Y., E. Kim, and T. S. Kim. 2005. Regulatory mechanisms and their therapeutic implications of interleukin-12 production in immune cells. Cell. Signal. 17: 665-673.
14. Karp, C. L., M. Wysocka, L. M. Wahl, J. M. Ahearn, P. J. Cuomo, B. Sherry, G. Trinchieri, and D. E. Griffin. 1996. Mechanism of suppression of cell-mediated immunity by measles virus. Science 273: 228-231.
15. Chehimi, J., S. E. Starr, I. Frank, A. D'Andrea, X. Ma, R. R. MacGregor, J. Sennelier, and G. Trinchieri. 1994. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 179: 1361-1366.
16. Matsunaga, K., T. W. Klein, C. Newton, H. Friedman, and Y. Yamamoto. 2001. Legionella pneumophila suppresses interleukin-12 production by macrophages. Infect. Immun. 69: 1929-1933.
17. Lee, C. H., Y. H. Choi, S. H. Yang, C. W. Lee, S. J. Ha, and Y. C. Sung. 2001. Hepatitis C virus core protein inhibits interleukin 12 and nitric oxide production from activated macrophages. Virology 279: 271-279.
18. Eisen-Vandervelde, A. L., S. N. Waggoner, Z. Q. Yao, E. M. Cale, C. S. Hahn, and Y. S. Hahn. 2004. Hepatitis C virus core selectively suppresses interleukin-12 synthesis in human macrophages by interfering with AP-1 activation. J. Biol. Chem. 279: 43479-43486.
19. Hahn, Y. S. 2003. Subversion of immune responses by hepatitis C virus: immunomodulatory strategies beyond evasion? Curr. Opin. Immunol. 15: 443-449.
20. Rehermann, B., and M. Nascimbeni. 2005. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 5: 215-229.
21. Shoukry, N. H., A. G. Cawthon, and C. M. Walker. 2004. Cell-mediated immunity and the outcome of hepatitis C virus infection. Annu. Rev. Microbiol. 58: 391-424.
22. Sarih, M., N. Bouchrit, and A. Benslimane. 2000. Different cytokine profiles of peripheral blood mononuclear cells from patients with persistent and self-limited hepatitis C virus infection. Immunol. Lett. 74: 117-120.
23. Kanto, T., N. Hayashi, T. Takehara, T. Tatsumi, N. Kuzushita, A. Ito, Y. Sasaki, A. Kasahara, and M. Hori. 1999. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J. Immunol. 162: 5584-5591.
24. Soguero, C., M. Joo, K. A. Chianese-Bullock, D. T. Nguyen, K. Tung, and Y. S. Hahn. 2002. Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model. J. Virol. 76: 9345-9354.
25. Large, M. K., D. J. Kittlesen, and Y. S. Hahn. 1999. Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence. J. Immunol. 162: 931-938.
26. Sarobe, P., J. J. Lasarte, A. Zabaleta, L. Arribillaga, A. Anna, I. Melero, F. Borras-Cuesta, and J. Prieto. 2003. Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses. J. Virol. 77: 10862-10871.
27. Kittlesen, D. J., K. A. Chianese-Bullock, Z. Q. Yao, T. J. Braciale, and Y. S. Hahn. 2000. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J. Clin. Invest. 106: 1239-1249.
28. Fingeroth, J. D., J. J. Weis, T. F. Tedder, J. L. Strominger, P. A. Biro, and D. T. Fearon. 1984. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc. Natl. Acad. Sci. USA 81: 4510-4514.
29. Braun, L., B. Ghebrehiwet, and P. Cossart. 2000. gC1q-R/p32, a C1q-binding protein, is a receptor for the In1B invasion protein of Listeria monocytogenes. EMBO J. 19: 1458-1466.
30. Nguyen, T., B. Ghebrehiwet, and E. I. Peerschke. 2000. Staphylococcus aureus protein A recognizes platelet gC1qR/p33: a novel mechanism for staphylococcal interactions with platelets. Infect. Immun. 68: 2061-2068.
31. Salhi, S., F. Messageot, D. Carlier, O. Jean-Jean, and J. M. Rossignol. 2001. Identification of a cellular protein specifically interacting with the precursor of the hepatitis B e antigen. J. Viral Hepat. 8: 169-173.
32. Hall, K. T., M. S. Giles, M. A. Calderwood, D. J. Goodwin, D. A. Matthews, and A. Whitehouse. 2002. The herpesvirus Saimiri open reading frame 73 gene product interacts with the cellular protein p32. J. Virol. 76: 11612-11622.
33. Liang, X., Y. C. Shin, R. E. Means, and J. U. Jung. 2004. Inhibition of interferon-mediated antiviral activity by murine gammaherpesvirus 68 latency-associated M2 protein. J. Virol 78: 12416-12427.
34. Martin, M., R. E. Schifferle, N. Cuesta, S. N. Vogel, J. Katz, and S. M. Michalek. 2003. Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide. J. Immunol. 171: 717-725.
35. Fukao, T., M. Tanabe, Y. Terauchi, T. Ota, S. Matsuda, T. Asano, T. Kadowaki, T. Takeuchi, and S. Koyasu. 2002. PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat. Immunol. 3: 875-881.
36. Fukao, T., and S. Koyasu. 2003. PI3K and negative regulation of TLR signaling. Trends Immunol. 24: 358-363.
37. Hirschfeld, M., Y. Ma, J. H. Weis, S. N. Vogel, and J. J. Weis. 2000. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J. Immunol. 165: 618-622.
38. Whitman, M., D. Kaplan, T. Roberts, and L. Cantley. 1987. Evidence for two distinct phosphatidylinositol kinases in fibroblasts: implications for cellular regulation. Biochem. J. 247: 165-174.
39. Ghebrehiwet, B., B. L. Lim, R. Kumar, X. Feng, and E. I. Peerschke. 2001. gC1q-R/p33, a member of a new class of multifunctional and multicompartmental cellular proteins, is involved in inflammation and infection. Immunol. Rev. 180: 65-77.
40. Grazia Cappiello, M., F. S. Sutterwala, G. Trinchieri, D. M. Mosser, and X. Ma. 2001. Suppression of IL-12 transcription in macrophages following Fey receptor ligation. J. Immunol. 166: 4498-4506.
41. Ma, X., and G. Trinchieri. 2001. Regulation of interleukin-12 production in antigen-presenting cells. Adv. Immunol. 79: 55-92.
42. Fan, H., and J. A. Cook. 2004. Molecular mechanisms of endotoxin tolerance. J. Endotoxin Res. 10: 71-84.
43. Vlahos, C. J., W. F. Matter, K. Y. Hui, and R. F. Brown. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1- benzopyran-4-one (LY294002). J. Biol. Chem. 269: 5241-5248.
44. Arcaro, A., and M. P. Wymann. 1993. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem. J. 296: 297-301.
45. Coffer, P. J., J. Jin, and J. R. Woodgett. 1998. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem. J. 335: 1-13.
46. Oppmann, B., R. Lesley, B. Blom, J. C. Timans, Y. Xu, B. Hunte, F. Vega, N. Yu, J. Wang, K. Singh, et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715-725.
47. Langrish, C. L., B. S. McKenzie, N. J. Wilson, R. de Waal Malefyt, R. A. Kastelein, and D. J. Cua. 2004. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol. Rev. 202: 96-105.
48. Ghebrehiwet, B., X. Feng, R. Kumar, and E. I. Peerschke. 2003. Complement component C1q induces endothelial cell adhesion and spreading through a docking/signaling partnership of CIq receptors and integrins. Int. Immunopharmacol 3: 299-310.
49. Pasare, C., and R. Medzhitov. 2004. Toll-like receptors: linking innate and adaptive immunity. Microbes Infect. 6: 1382-1387.
50. Braun, M. C., E. Lahey, and B. L. Kelsall. 2000. Selective suppression of IL-12 production by chemoattractants. J. Immunol. 164: 3009-3017.
51. Wittmann, M., J. Zwirner, V. A. Larsson, K. Kirchhoff, G. Begemann, A. Kapp, O. Gotze, and T. Werfel. 1999. C5a suppresses the production of IL-12 by IFN-γ-primed and lipopolysaccharide-challenged human monocytes. J. Immunol. 162: 6763-6771.
52. Hawlisch, H., Y. Belkaid, R. Baelder, D. Hildeman, C. Gerard, and J. Kohl. 2005. C5a negatively regulates Toll-like receptor 4-induced immune responses. Immunity 22: 415-426.
53. Guermonprez, P., J. Valladeau, L. Zitvogel, C. Thery, and S. Amigorena. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20: 621-667.